COVID-19 Impact on ACTH Deficiencyin Pharmaceutical Industry
Overview
Impact on Pharmaceutical Industry
The COVID-19 pandemic has posed several kinds of challenges in front of different types of industries which have badly impacted the worldwide economy. The lockdown triggered due to continuous pandemic has led to the disruption of manufacturing and supply activities which has jolted the pharmaceutical sectors among others. Larger players having deeper pockets became able to compensate themselves under such pandemic situations however the smaller companies fall under the stress due to lack of sufficient capital, source of income, and ban on import-export activities among several other factors.
Moreover, vigorous research activities conducted by the pharmaceutical players have affected the research and development activities required for boosting up the growth of another pharmaceutical market.

COVID-19 Impacts on Adrenal Gland
COVID-19 caused by the SARS-CoV-2 virus has been reported not only to affect the major respiratory parts but also affects the other body organs and hinders the body’s metabolic process which leads to life-threatening diseases.
Adrenocorticotropic hormone (ACTH) is produced and secreted by the anterior pituitary gland and is also called serum ACTH, corticotropin among others. ACTH is responsible for maintaining the level of cortisol hormone which is regulated by the adrenal gland. Insufficient ACTH production leads to adrenal malfunctions and pituitary tumors. Decreased production of ACTH has also been reported to cause adrenal insufficiency which results in nausea, anorexia, weight loss among others.
The below table demonstrates the amount of different cellular molecules in normal person and person suffering from adrenal insufficiency.
Table: 1 Laboratory Findings of Patients with Adrenal Sufficiency Vs. Those with Adrenal Insufficiency
Read in detail...